Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 65.06 CNY -6.19% Market Closed
Market Cap: ¥10.9B

Operating Margin

15.7%
Current
Declining
by 1.2%
vs 3-y average of 17%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.7%
=
Operating Income
¥124.9m
/
Revenue
¥794.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.7%
=
Operating Income
¥124.9m
/
Revenue
¥794.5m

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Acrobiosystems Co Ltd
SZSE:301080
10.9B CNY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Higher than 81% of companies in China
Percentile
81st
Based on 8 544 companies
81st percentile
15.7%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Acrobiosystems Co Ltd
Glance View

Market Cap
10.9B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
43.04 CNY
Overvaluation 34%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
15.7%
=
Operating Income
¥124.9m
/
Revenue
¥794.5m
What is Acrobiosystems Co Ltd's current Operating Margin?

The current Operating Margin for Acrobiosystems Co Ltd is 15.7%, which is below its 3-year median of 17%.

How has Operating Margin changed over time?

Over the last 3 years, Acrobiosystems Co Ltd’s Operating Margin has decreased from 33.8% to 15.7%. During this period, it reached a low of 8.7% on Sep 30, 2024 and a high of 33.8% on Aug 30, 2022.

Back to Top